AbbVie Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
03-01

DJ AbbVie Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of AbbVie Inc. $(ABBV)$ rallied 1.96% to $209.03 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.59% to 5,954.50 and the Dow Jones Industrial Average rising 1.39% to 43,840.91.

This was the stock's second consecutive day of gains.

AbbVie Inc. hit a new 52-week high, surpassing its previous peak of $207.32, which the company reached on October 31st.

The stock outperformed some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 0.79% to $165.02, Pfizer Inc. $(PFE)$ rose 1.26% to $26.43, and Amgen Inc. $(AMGN)$ rose 0.73% to $308.06.

Trading volume (12.5 M) eclipsed its 50-day average volume of 5.9 M.

Data source: Dow Jones Market Data, FactSet. Data compiled February 28, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

February 28, 2025 16:31 ET (21:31 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10